Cognitive impairment is a common and devastating manifestation of multiple sclerosis (MS).
Although disease-modifying therapies have been efficacious for reducing relapse rates in …

Multiple sclerosis (MS) is an immune-mediated disease of the central nervous system
characterized by focal or diffuse inflammation, demyelination, axonal loss and …

The exact etiology of Parkinson's disease (PD) remains unclear. Some evidence supports
Helicobacter pylori infection as a trigger or driving event, but detection and eradication of H …

Cognitive impairment is a common and debilitating symptom in multiple sclerosis (MS).
There is limited evidence that disease-modifying therapies are effective in treating cognitive …

Abstract Lower Urinary Tract Symptoms (LUTS) are frequently present in the general
population as patients age with approximately a third of individuals experiencing LUTS …

Background. Cognitive impairments are common in people with multiple sclerosis (MS).
Systematic reviews reported promising evidence for various cognitive interventions in this …

Cognitive training (CT) is an increasingly popular, non-pharmacological intervention for
improving cognitive functioning in neurodegenerative diseases and healthy aging. Although …

Background and Purpose. There is an increasing interest in the effect of
nonpharmacological interventions on the course of patients with Alzheimer's disease (AD) …

Multiple sclerosis (MS) is the most common cause of non-traumatic disability in people aged
10–65 years. Evidence exists for the effectiveness of multidisciplinary rehabilitation and …

Education, occupation, and an active lifestyle, comprising enhanced social, physical, and
mental components are associated with improved cognitive functions in aged people and …